David Ryberg

5.3k total citations
51 papers, 3.3k citations indexed

About

David Ryberg is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, David Ryberg has authored 51 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 17 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in David Ryberg's work include Carcinogens and Genotoxicity Assessment (10 papers), Glutathione Transferases and Polymorphisms (10 papers) and RNA modifications and cancer (10 papers). David Ryberg is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Glutathione Transferases and Polymorphisms (10 papers) and RNA modifications and cancer (10 papers). David Ryberg collaborates with scholars based in Norway, United States and Italy. David Ryberg's co-authors include Aage Haugen, David H. Phillips, Vidar Skaug, Shanbeh Zienolddiny, Lodve Stangeland, Federico Canzian, Helge Lind, Jan Alexander, Daniele Campa and Astrid C. Haugen and has published in prestigious journals such as The Science of The Total Environment, Environmental Health Perspectives and British Journal of Cancer.

In The Last Decade

David Ryberg

50 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ryberg Norway 26 2.0k 1.2k 895 711 476 51 3.3k
Sisko Anttila Finland 36 2.1k 1.1× 1.3k 1.1× 950 1.1× 323 0.5× 1.2k 2.4× 91 4.6k
Da‐Tian Bau Taiwan 34 2.1k 1.0× 921 0.8× 691 0.8× 409 0.6× 234 0.5× 163 3.6k
Marshall W. Anderson United States 32 1.5k 0.7× 1.0k 0.9× 697 0.8× 162 0.2× 375 0.8× 95 2.6k
Anna Jakubowska Poland 33 1.7k 0.9× 886 0.8× 774 0.9× 685 1.0× 317 0.7× 188 3.8k
Amina Amadou France 15 1.5k 0.7× 1.1k 1.0× 1.0k 1.1× 291 0.4× 576 1.2× 38 3.7k
Takuma Nemoto United States 29 856 0.4× 1.1k 1.0× 1.6k 1.8× 737 1.0× 468 1.0× 57 3.5k
Maurizio Montella Italy 37 1.1k 0.6× 852 0.7× 1.2k 1.4× 535 0.8× 346 0.7× 105 3.8k
Marco A. De Velasco Japan 33 1.8k 0.9× 664 0.6× 978 1.1× 387 0.5× 632 1.3× 115 3.2k
Manuela Gago-Domínguez United States 29 876 0.4× 639 0.6× 570 0.6× 158 0.2× 378 0.8× 51 2.6k
Shugo Suzuki Japan 32 1.1k 0.6× 467 0.4× 342 0.4× 157 0.2× 387 0.8× 141 2.6k

Countries citing papers authored by David Ryberg

Since Specialization
Citations

This map shows the geographic impact of David Ryberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ryberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ryberg more than expected).

Fields of papers citing papers by David Ryberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ryberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ryberg. The network helps show where David Ryberg may publish in the future.

Co-authorship network of co-authors of David Ryberg

This figure shows the co-authorship network connecting the top 25 collaborators of David Ryberg. A scholar is included among the top collaborators of David Ryberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ryberg. David Ryberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zienolddiny, Shanbeh, Vidar Skaug, Nina E. Landvik, et al.. (2009). The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis. 30(8). 1368–1371. 83 indexed citations
2.
Campa, Daniele, Shanbeh Zienolddiny, Helge Lind, et al.. (2006). Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer. Lung Cancer. 56(1). 17–23. 37 indexed citations
3.
Zienolddiny, Shanbeh, Daniele Campa, Helge Lind, et al.. (2005). Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 27(3). 560–567. 335 indexed citations
4.
Kjuus, Helge, I.L. Hansteen, David Ryberg, et al.. (2005). Chromosome aberrations in tunnel workers exposed to acrylamide and N-methylolacrylamide. Scandinavian Journal of Work Environment & Health. 31(4). 300–306. 26 indexed citations
5.
Vineis, Paolo, Fabrizio Veglia, Sisko Anttila, et al.. (2004). CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene–gene interactions. Biomarkers. 9(3). 298–305. 41 indexed citations
6.
Zienolddiny, Shanbeh, David Ryberg, Valentina Maggini, et al.. (2004). Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancer. International Journal of Cancer. 109(3). 353–356. 115 indexed citations
7.
Skúladóttir, Halla, Herman Autrup, Judith L. Autrup, et al.. (2004). Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. Lung Cancer. 48(2). 187–199. 39 indexed citations
8.
Zienolddiny, Shanbeh, Debbie Hege Svendsrud, David Ryberg, Aase B. Mikalsen, & Aage Haugen. (2000). Nickel(II) induces microsatellite mutations in human lung cancer cell lines. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 452(1). 91–100. 20 indexed citations
9.
Lindstedt, Bjørn-Arne, David Ryberg, & Aage Haugen. (1997). Rare alleles at different VNTR loci among lung-cancer patients with microsatellite instability in tumours. International Journal of Cancer. 70(4). 412–415. 15 indexed citations
10.
Ryberg, David. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18(7). 1285–1289. 353 indexed citations
11.
Kure, Elin H., David Ryberg, Alan Hewer, et al.. (1996). p53mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 17(10). 2201–2205. 145 indexed citations
12.
Haugen, Aage, Lovise Mæhle, Sarah Mollerup, Edgar Rivedal, & David Ryberg. (1994). Nickel-induced alterations in human renal epithelial cells.. Environmental Health Perspectives. 102(suppl 3). 117–118. 16 indexed citations
13.
Hovig, Eivind, Birgitte Smith‐Sørensen, Mark C. Gebhardt, et al.. (1992). No alterations in exon 21 of the RBI gene in sarcomas and carcinomas of the breast, colon, and lung. Genes Chromosomes and Cancer. 5(2). 97–103. 8 indexed citations
14.
Ryberg, David, Toril Tefre, Vidar Skaug, et al.. (1992). Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.. Environmental Health Perspectives. 98. 187–189. 4 indexed citations
15.
16.
Ryberg, David & Jan Alexander. (1990). Mechanisms of chromium toxicity in mitochondria. Chemico-Biological Interactions. 75(2). 141–151. 43 indexed citations
17.
Haugen, Aage, David Ryberg, Inger‐Lise Hansteen, & Paul Amstad. (1990). Neoplastic transformation of a human kidney epithelial cell line transfected with V‐HA‐ras oncogene. International Journal of Cancer. 45(3). 572–577. 10 indexed citations
18.
Ryberg, David, Toril Tefre, Vidar Skaug, et al.. (1990). Ha-ras-1 alleles in Norwegian lung cancer patients. Human Genetics. 86(1). 40–4. 14 indexed citations
19.
Mikalsen, Arne, Jan Alexander, & David Ryberg. (1989). Microsomal metabolism of hexavalent chromium. Inhibitory effect of oxygen and involvement of cytochrome P-450. Chemico-Biological Interactions. 69(2-3). 175–192. 20 indexed citations
20.
Haugen, Aage, David Ryberg, Inger‐Lise Hansteen, & Helge Dalen. (1989). Transformation of human kidney epithelial cells to tumorigenicity by nickel(II) and V-HA-RAS oncogene. Biological Trace Element Research. 21(1). 451–458. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sisko Anttila Breakdown of academic impact, for papers by Da‐Tian Bau Breakdown of academic impact, for papers by Marshall W. Anderson Breakdown of academic impact, for papers by Anna Jakubowska Breakdown of academic impact, for papers by Amina Amadou Breakdown of academic impact, for papers by Takuma Nemoto Breakdown of academic impact, for papers by Maurizio Montella Breakdown of academic impact, for papers by Marco A. De Velasco Breakdown of academic impact, for papers by Manuela Gago-Domínguez Breakdown of academic impact, for papers by Shugo Suzuki
Rankless by CCL
2026